What's New
FTD in the News
Treat FTD Fund Grant Recipient Discusses FTD-GRN Gene Therapy in Newspaper Interview
Simon Ducharme, MD, MSc, FRCPC, of McGill University, a recent recipient of a grant through the Treat…
FDA Grants Breakthrough Therapy Designation to Experimental FTD Therapy
The U.S. Food and Drug Administration (FDA) has granted a “breakthrough therapy designation” to latozinemab, an experimental…
UK Researchers Discover How to Block Toxic Protein Associated with FTD and ALS
Researchers at the University of Sheffield have discovered how to prevent the production of toxic repeat proteins…
“The Longest Goodbye”: Montana Woman Shares Family’s FTD Journey in Interview
Krista Payzant of Montana characterized FTD as a thief that “strips the person of who they are”…
NY State Senator Michelle Hinchey Introduces Bill to Create State FTD Registry
New York State Senator Michelle Hinchey introduced a bill on January 3 to create a statewide FTD…
Researcher Discusses Integrating Genetic Testing Into Routine FTD/ALS Care in Podcast Interview
Offering genetic testing to persons diagnosed with FTD/ALS disorders should be a routine part of clinical care,…
News Report on Tallahassee Couple’s FTD Journey Highlights Challenges of Misdiagnosis
A report aired by Tallahassee news station WTXL27 shares how FTD has affected the lives of a…
Public Benefits When Notable Names Share Neurological Challenges, UCLA Professor Writes
In an opinion piece published last month in the Los Angeles Times, Keith Vossel, MD, of the…
AFTD and ADDF Extend Treat FTD Fund Program Through 2035
AFTD and the Alzheimer’s Drug Discovery Foundation (ADDF) have committed to extending the Treat FTD Fund program…
Passage Bio Announces Hopeful Initial Data from Phase 1/2 Clinical Trial
Passage Bio released promising preliminary results from its phase 1/2 clinical trial evaluating an experimental treatment for…
English 
Spanish (Mexico) 
French 
German 
Swedish 
Portuguese 
Italian 
Dutch 
Danish 
Polish 
Spanish (Spain)